Acadia Pharmaceuticals Files 8-K on Financials
Ticker: ACAD · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1070494
| Field | Detail |
|---|---|
| Company | Acadia Pharmaceuticals Inc (ACAD) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ACAD
TL;DR
ACAD filed an 8-K on Aug 6th, check it for financial updates.
AI Summary
Acadia Pharmaceuticals Inc. filed an 8-K on August 6, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's principal executive offices located at 12830 El Camino Real, Suite 400, San Diego, California, 92130.
Why It Matters
This filing provides an update on Acadia Pharmaceuticals' financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- ACADIA PHARMACEUTICALS INC (company) — Registrant
- August 06, 2025 (date) — Date of Report
- 12830 El Camino Real, Suite 400, San Diego, California, 92130 (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of the financial results are not provided in the excerpt.
When was this 8-K report filed?
The report was filed on August 6, 2025.
What is the primary business of Acadia Pharmaceuticals Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Acadia Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 12830 El Camino Real, Suite 400, San Diego, California, 92130.
What is the Commission File Number for Acadia Pharmaceuticals Inc.?
The Commission File Number is 000-50768.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding ACADIA PHARMACEUTICALS INC (ACAD).